Contralateral prophylactic mastectomy associated with survival in select breast cancer patients
EurekAlert!
Contact: Laura Sussman lsussman@mdanderson.org
713-745-2457
University of Texas M. D. Anderson Cancer Center
Public release date: 25-Feb-2010
First large, population-based study to find an association between procedure and survival; findings offer data for women making difficult, personal decision
ScienceDaily (Feb. 23, 2010) — The presence of certain proteins in premalignant oral lesions may predict oral cancer development, Medical College of Georgia researchers said.
SIBLINGs, or Small Integrin-Binding Ligand N-linked Glycoproteins, are a family of five proteins that help mineralize bone but can also spread cancer. SIBLINGs have been found in cancers including breast, lung, colon and prostate.
"Several years ago we discovered that three SIBLINGs -- osteopontin,...
Julie Steenhuysen
CHICAGO
Mon Feb 22, 2010 2:51pm EST
CHICAGO (Reuters) - Some U.S. states have begun using controversial new breast cancer screening guidelines to stop offering routine mammograms for uninsured women in their 40s, a survey by the Avon Foundation for Women released on Monday found.
The Avon survey of more than 150 breast cancer health educators and providers from 48 states and Washington, D.C. found a quarter of the states have either cut or...
Reversing Resistance to Sunitinib: Findings May Help Patients With Deadly Kidney Cancer
ScienceDaily (Feb. 19, 2010) — Van Andel Research Institute (VARI) researchers have found a way to reverse resistance to sunitinib, a treatment that is currently the first line of defense against clear cell renal cell carcinoma (ccRCC), a deadly form of kidney cancer. Most patients who show a positive response to sunitinib develop a resistance to the drug after one year of treatment.
Julie Steenhuysen
CHICAGO
Thu Feb 18, 2010 3:41pm EST
CHICAGO (Reuters) - A personalized blood test can tell whether a patient's cancer has spread or come back, offering a better way to see if treatments are working, U.S. researchers said on Thursday.
Having a test that can detect tumors in the blood could help doctors customize cancer treatments, offering more aggressive therapy to some patients while sparing others from unneeded chemotherapy or radiation....
